Why is Emmessar Biotech falling/rising?

As of 15-Sep, Emmessar Biotech & Nutrition Ltd is currently priced at Rs 27.00, reflecting an increase of Rs 0.59 or 2.23%. The stock has shown a trend reversal by gaining after three consecutive days of decline. Despite this recent uptick, it is still trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. The stock is also close to its 52-week low, being only 4.44% away from Rs 25.8. However, there has been a notable increase in investor participation, with delivery volume rising by 53.81% against the 5-day average, suggesting a potential shift in market sentiment.
In the broader market context, Emmessar Biotech's short-term performance has been underwhelming compared to the benchmark Sensex, which has gained 1.24% over the past week while Emmessar Biotech has declined by 0.88%. Over the past month, the stock has decreased by 2.88%, contrasting with the Sensex's increase of 1.47%. Year-to-date, Emmessar Biotech has experienced a significant decline of 41.68%, while the Sensex has risen by 4.67%. This disparity highlights the challenges faced by Emmessar Biotech in the current market environment, despite the recent positive movement in its stock price.